Organon
Healthcare
Pharma firm Leeford Healthcare plans maiden private equity round
Pharmaceutical company Leeford Healthcare Ltd is planning to sell a minority stake in its maiden institutional private ......
Healthcare
ChrysCap, two other PE firms vying for stake in domestic formulations maker
A clutch of private equity investors including ChrysCapital, Malaysia's Creador and Bahrain-headquartered Investcorp......
Healthcare
PE-backed drugmaker Brinton eyes fresh fundraise, hires banker
Pune-based drugmaker Brinton Pharmaceuticals Ltd is planning a fresh equity round of funding after a hiatus of nearly ......
Healthcare
PE firms circle Tata Capital Healthcare-backed Linux Laboratories
Linux Laboratories Pvt Ltd, a pharmaceutical company focussed on central nervous system (CNS) therapies, is in talks ......
Finance
Deals Digest: PE-VC deal value recovers; Sun Pharma's Organon buy boosts M&As
Private equity (PE) and venture capital (VC) deal value recovered sharply this week, even as activity cooled. Meanwhile......
Healthcare
Sun Pharma to acquire US-listed Organon in $11.75-bn deal
Sun Pharmaceutical Industries will acquire Organon & Co in an all‑cash deal, valuing the U.S. drugmaker at about $11.......
General
Grapevine: TPG, GIC, CPPIB, Sun Pharma, Jubilant, others in news
Sun Pharma has tabled a new binding offer for US-based Organon, marking its biggest global bet yet, while institutional ......
General
Grapevine: upGrad, Sun Pharma, Blume, Qualcomm Ventures, others in news
Sun Pharmaceutical Industries is a step closer to buying US drugmaker Organon while edtech startup upGrad is witnessing ......
General
Grapevine: Sun Pharma, Organon, Blackstone, Neysa, Medsource Ozone in news
Sun Pharmaceutical Industries is weighing a potential acquisition of US‑based women’s health and biosimilars player......








